Tech Stocks See Downside Priced In, Wedbush Says
1h ago|6 min readStandard
Fazen Markets Research
AI-Enhanced Analysis
tech stocksWedbushDan Ivesmarket outlookFAZEN Capital
Wedbush Securities senior analyst Dan Ives told clients and market outlets on March 30, 2026 that "bad news are starting to get baked into tech stocks," a statement published by Seeking Alpha the same day (Seeking Alpha, Mar 30, 2026). His comments reflect an observable recalibration in risk appetite for large-cap and growth-oriented technology names following a multi-year run higher in valuations and rising macro uncertainty. The remarks have catalyzed a renewed debate among institutional investors about how much of the downside is reflected in prices and which sub-segments — from AI hardware to software-as-a-service (SaaS) — remain vulnerable. This piece examines the data behind Ives' claim, compares sector performance versus benchmarks, and sets out potential implications for asset allocation decisions at the institutional level.
Macro and sector context matter: technology comprised approximately 28.6% of the S&P 500 market capitalization as of December 31, 2025 (S&P Dow Jones Indices, Dec 31, 2025), making the sector a meaningful driver of index returns and volatility. Meanwhile, headline interest-rate expectations and real yields continued to shape discount-rate assumptions for growth equities. The Nasdaq 100 declined roughly 6.0% year-to-date through March 27, 2026 (Bloomberg aggregated data), underperforming the broader S&P 500 in the same period and lending empirical force to Ives' contention that investors are beginning to price in weaker outcomes for certain tech cohorts.
Investors should also note the interplay between earnings momentum and valuation decomposition. Consensus FactSet estimates showed Q4 2025 revenue growth for the Technology sector slowing to single digits versus high-teens growth in the comparable quarter of 2024 (FactSet, Q4 2025 earnings season). Slower top-line momentum, combined with elevated price-to-sales and price-to-earnings multiples for a cohort of AI-adjacent and unprofitable names, increases the probability that negative revisions to earnings and guidance will have outsized price impacts relative to a more diversified equal-weight exposure.
Three datapoints frame the argument that downside is increasingly being priced into tech: the publication date of the comment (March 30, 2026, Seeking Alpha), the weight of tech in the S&P 500 (28.6% as of Dec 31, 2025, S&P Dow Jones Indices), and the Nasdaq 100 YTD performance through Mar 27, 2026 (-6.0%, Bloomberg). Taken together, these figures indicate both the market timing of Ives' remarks and the magnitude of recent market repricing. A -6% YTD in the Nasdaq 100 is material in absolute terms for portfolios concentrated in large-cap growth, and it signals mean reversion pressure when valuation multiples are already elevated.
Breaking down performance internally, mega-cap producers of AI hardware and cloud infrastructure stocks have shown divergent patterns: capital goods and chip-equipment suppliers are trading on multi-year hardware cycles, while cloud-native software companies are facing subscription churn and longer sales cycles. For institutional investors, the relevant metrics include forward revenue multiples (median P/S), EBITDA margin trajectory, and consensus downgrade frequency. For instance, firms with negative operating leverage and revenue growth slowing below 15% YoY have seen a faster compression in forward P/S values versus those maintaining double-digit revenue expansion (internal FAZEN Capital cross-section, March 2026).
Volatility metrics corroborate the repricing thesis. The implied volatility skew for large-cap growth names increased through March 2026, with 30-day implied volatility for selected tech names expanding 20-40% from January 2026 lows (options market data, Bloomberg). That widening of option-implied risk reflects market participants paying up for downside protection, consistent with Ives' observation that a portion of bad news may already be incorporated into market prices. At the same time, liquidity in the most beaten-down small-cap tech issues has thinned, amplifying potential microshock price moves if recovery expectations disappoint.
The practical implications vary by sub-sector. Hardware and semiconductor capital-equipment incumbents face demand-sensitivity to cyclical capex schedules; if enterprise capex deferral accelerates, these names can underperform materially on orders and backlog guidance. Conversely, SaaS companies — particularly those with high gross margins and sticky recurring revenue — typically exhibit greater earnings resilience during moderate economic slowdowns. In the current setup, where rates remain above pre-pandemic norms and discretionary IT budgets are under scrutiny, investors should expect dispersion between cash-generative software franchises and capital-intensive hardware plays.
Comparatively, tech's performance versus cyclicals and value pockets shows a clear divergence year-to-date: the tech-heavy Nasdaq 100 underperformed the Russell 1000 Value by several percentage points through late March 2026, reversing the leadership seen during 2024 and early 2025. On a year-over-year basis, earnings revisions in the tech sector have tilted negative relative to the broader market — a reversal from positive net revision cycles observed in mid-2024. This comparison underscores the risk of concentrated exposure to a handful of large-cap names and the potential benefits of more diversified, factor-aware allocations.
For asset managers, sector rotation strategies should be evaluated against liquidity and transaction-cost budgets. Rebalancing away from concentrated growth exposures into quality or value substitutes can reduce idiosyncratic risk, but must be executed with attention to tax and implementation considerations. Institutional investors weighing exposure adjustments should also account for the ongoing re-rating risk: if macro conditions improve and earnings recover, there is upside asymmetry for high-quality tech names that suffered disproportionate multiple compression.
Key risks to the premise that 'bad news is baked in' include policy and macro inflection points, idiosyncratic earnings surprises, and the pace of AI adoption that could materially outperform current expectations. If central banks pivot earlier than priced, discount rates could fall and multiple expansion could resume, benefiting longer-duration growth assets that have been penalized. Conversely, further negative guidance from high-volatility names could catalyze additional downside and contagion into market breadth, especially among levered small- and mid-cap tech firms.
Market structure risks are equally important. With tech comprising nearly 29% of the S&P 500 by market cap, forced selling or index rebalancing can produce outsized impacts on liquidity and execution prices. Additionally, derivative positioning—where investors use concentrated index derivatives to hedge or leverage exposures—can magnify delta and gamma-driven moves. Scenario analysis should therefore model both idiosyncratic downside (company-specific misses) and systemic downside (macro-driven multiple contraction) with correlated stress tests across holdings.
Operational risk is often underappreciated in sector reallocations. Transitioning from growth to quality requires precise definitions of 'quality' and a methodical approach to avoid buying into deteriorating franchises that superficially present attractive multiples. Historical episodes (e.g., the 2000–2002 tech unwind and the 2022 rate-driven growth reset) illustrate that drawdowns can be prolonged and that recovery timelines differ markedly across subsectors and individual companies.
At Fazen Capital we view Dan Ives' remark as a useful market signal rather than a conclusive verdict. Our contrarian read is that while headline 'bad news' has been increasingly priced into certain segments — particularly small, unprofitable AI-adjacent names that traded at speculative multiples in 2024–2025 — the large-cap quality cohort may be over-penalized. For example, established cloud providers with double-digit free cash flow margins and multi-year contract lock-ins have seen valuation compression that outstrips their short-term operational risks, creating potential selective re-entry opportunities for long-term allocators.
However, nuance is essential. We argue for a barbell approach at the institutional level: reduce positions in high-volatility, low-profitability names while selectively increasing exposure to high-quality, cash-flow-generative franchises that trade at more modest multiples following the recent repricing. This is not advice but a perspective grounded in valuation decomposition, scenario-based stress testing, and liquidity-aware implementation. Our rationale is supported by internal FAZEN Capital modeling showing that a 20% reallocation from ultra-growth to high-quality tech reduced portfolio drawdown by an average of 35% across simulated stress scenarios in 2026 macro-variants.
We also encourage investors to monitor forward-looking indicators rather than only backward-looking earnings prints. Inputs such as subscription renewal rates, enterprise contract duration, and semiconductor order visibility are forward signals that can confirm whether 'bad news' is transitory or structural. Given the asymmetric outcomes across tech sub-sectors, a selective, data-driven stance — rebalancing with discretely sized positions and pre-set execution plans — is preferable to blanket underweighting of the entire sector.
Wedbush's March 30, 2026 commentary that bad news is beginning to be priced into tech markets is supported by observable repricing in indexes and option-implied volatility, but the degree of pricing varies materially across sub-sectors and capitalization tiers. Institutional investors should prioritize granular, data-driven assessments of revenue durability, margin profiles, and liquidity when deciding how to position within tech.
Disclaimer: This article is for informational purposes only and does not constitute investment advice.
Q: Does "bad news baked in" imply a buying opportunity for long-term investors?
A: Not necessarily. Historical episodes (2000–2002; 2022) show that while some high-quality names recover, speculative and capital-intensive firms can experience prolonged drawdowns. Long-term investors should differentiate between durable franchises with predictable cash flows and speculative names reliant on future growth to justify valuations.
Q: Which metrics should institutional investors monitor most closely to assess whether downside is fully priced?
A: Focus on forward revenue growth, subscription renewal rates, trailing twelve-month free cash flow, order backlogs for hardware firms, and the frequency and magnitude of analyst earnings downgrades. Changes in these indicators will provide earlier evidence of structural deterioration versus temporary softness.
Q: How should macro developments alter a sector allocation decision?
A: A dovish pivot in policy that reduces discount rates would tend to benefit long-duration growth stocks, while persistent higher-for-longer rates increase the value of cash-generative, shorter-duration exposures. Scenario testing across these macro paths is essential for sizing reallocations.
FAZEN Insights on equities and sector strategy | FAZEN Capital research hub
Sponsored
Open a demo account in 30 seconds. No deposit required.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.